| ASICs | Acid-sensing ion channels |
| BKCa | Large-conductance calcium-activated potassium channel |
| CaCCs | Calcium-activated chloride channels |
| CAF | Cancer-associated fibroblast |
| CCBs | Calcium channel blockers |
| CF | Cystic fibrosis |
| CFTR | Cystic fibrosis transmembrane conductance regulator |
| CSC | Cancer stem cell |
| ECM | Extracellular matrix |
| EMT | Epithelial-mesenchymal transition |
| ENaCs | Epithelial Na+ channels |
| GABAA-Rs | Gamma-aminobutyric acid type A receptors |
| GlyRs | Glycine receptors |
| HCC | Hepatocellular carcinoma |
| HNSCC | Head and neck squamous cell carcinoma |
| IKCa | Intermediate-conductance calcium-activated potassium channel |
| K2P | Two-pore domain potassium channels |
| KCa | Calcium-activated potassium channels |
| Kir | Inwardly rectifying potassium channels |
| KV | Voltage-gated potassium channels |
| LGCCs | Ligand-gated calcium channels |
| LGClCs | Ligand-gated chloride channels |
| NPC | Nasopharyngeal carcinoma |
| NSCLC | Non-small-cell lung cancer |
| OSCC | Oral squamous cell carcinoma |
| PDAC | Pancreatic ductal adenocarcinoma |
| SCLC | Small-cell lung cancer |
| SKCa | Small-conductance calcium-activated potassium channel |
| SOCCs | Store-operated calcium channels |
| SOCE | Store-operated calcium entry |
| TAMs | Tumor-associated macrophages |
| TME | Tumor microenvironment |
| TMs | Transmembrane domains |
| TMZ | Temozolomide |
| TNBC | Triple-negative breast cancer |
| TRP | Transient receptor potential |
| TTX | Tetrodotoxin |
| VGCCs | Voltage-gated calcium channels |
| VGSC | Voltage-gated sodium channel |
| VRACs | Volume-regulated anion channels |